- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01773447
Set-back Suture Versus Traditional Vertical Mattress Suture
March 29, 2017 updated by: University of California, Davis
Comparing Wound Eversion and Clinical Outcomes in Surgical Wound Repair With Subcuticular Set-back Versus Traditional Vertical Mattress Suturing Techniques
The investigators hope to compare two different methods of closing skin wounds using sutures.
One of these methods (the set-back technique) was recently described in 2010 and has been reported to be technically easier and reduces the chance of spitting sutures (deep sutures that are pushed to the surface of the skin as the wound heals).
The other method (the vertical mattress technique) has been used for many years with good results.
However, no controlled studies have been performed to clearly demonstrate a difference between the two methods.
We hope to find differences in the height of the wound edges immediately after surgery(5 minutes following the procedure) as well as the appearance of the scar and symptoms associated with the scar 3 months after surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95816
- UC Davis, Department of Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elliptical surgical wound that needs to be closed with a layered closure
- Wound 3 cm in length or longer
Exclusion Criteria:
- Incarceration
- Active pregnancy
- Less than 18 years of age
- Unable to give informed consent
- Non-English or Dutch speaking (the scar assessment scale described below has only been validated in the English and Dutch languages)
- Wound closure projected to be less than 3 cm in length
- Skin less than 3 mm in thickness (dermis and epidermis combined)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Set-back suture
Wound to be close by set-back suture technique.
|
|
|
Active Comparator: Vertical mattress suture technique
Wound to be closed by vertical mattress technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean of sum of 2 blinded reviewers Physician Observer Assessment scores
Time Frame: 3 months
|
Compare the functional and cosmetic outcomes of the two sutured halves of each scar at 3 months follow-up as follows: a. Use a previously validated scar assessment scale called the Patient and Observer Scar Assessment Scale, specifically the averaged sum of the total score of 2 blinded observers. |
3 months
|
|
Scar width
Time Frame: 3 months
|
Width of scar in millimeters for each side of scar measured 1 cm from the midline.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height of scar immediately following wound closure
Time Frame: 5 minutes
|
Height of each side of the wound will be measured 1 cm from the midpoint of the wound in millimeters
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
January 15, 2013
First Submitted That Met QC Criteria
January 18, 2013
First Posted (Estimate)
January 23, 2013
Study Record Updates
Last Update Posted (Actual)
March 31, 2017
Last Update Submitted That Met QC Criteria
March 29, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 247354
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Melanoma
-
National Cancer Institute (NCI)RecruitingMucosal Melanoma | Anal Melanoma | Bladder Melanoma | Cervical Melanoma | Esophageal Melanoma | Gallbladder Melanoma | Oral Cavity Mucosal Melanoma | Penile Mucosal Melanoma | Rectal Melanoma | Recurrent Mucosal Melanoma | Sinonasal Mucosal Melanoma | Urethral Melanoma | Vaginal Melanoma | Vulvar Melanoma | Head and... and other conditionsUnited States, Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IA Melanoma | Stage IB Melanoma | Stage IIA MelanomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of VirginiaCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin Melanoma | Stage 0 Skin Melanoma | Stage I Skin Melanoma | Stage II Skin MelanomaUnited States
-
MelanomaPRO, RussiaRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma, Stage II | Melanoma, Uveal | Melanoma in Situ | Melanoma, OcularRussian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteTurnstone Biologics, Corp.CompletedMetastatic Melanoma | Conjunctival Melanoma | Ocular Melanoma | Unresectable Melanoma | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Iris Melanoma | Acral Melanoma | Non-Cutaneous MelanomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIB Melanoma | Stage IIC MelanomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IV Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage...United States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Unresectable Mucosal Melanoma | Advanced Cutaneous Melanoma | Metastatic Mucosal Melanoma | Advanced Mucosal Melanoma | Metastatic Acral Melanoma | Unresectable Acral Melanoma | Advanced Acral...United States
-
Fudan UniversityNot yet recruiting
Clinical Trials on Set-back suture
-
Sun Yat-sen UniversityNot yet recruiting
-
National Heart Centre SingaporeRecruiting
-
Antalya Health Sciences UniversityRecruitingMortality | Trauma (Including Fractures) | Trauma Centers | Helmet Use | Motorsycle | Severity ScoreTurkey (Türkiye)
-
Montefiore Medical CenterCompletedSurgical Wound Infection | Complications; Cesarean SectionUnited States
-
Texas A&M UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingGlucose Metabolism | Amino Acid MetabolismUnited States
-
Fujian Shengdi Pharmaceutical Co., Ltd.RecruitingSevere Hypertriglyceridemia With a High Risk of Acute PancreatitisChina
-
Hadassah Medical OrganizationUnknownOral Surgical Procedures
-
Tianjin Eye HospitalRecruitingPrimary PterygiumChina
-
Bradley HospitalNational Institute of Mental Health (NIMH)CompletedLow-immersion (Mobile Device) | High-immersion (Head Mounted Display)United States
-
Bassett HealthcareTerminatedHip FracturesUnited States